Published On:April 21 2020
Story Viewed 1430 Times

Smruthi Organics Ltd. acquires license for manufacturing HCQ at its Solapur plant.

Responding to the need of the hour in this fight against Covid-19, the company has acquired manufacturing license for APIs Hydroxy Chloroquine (HCQ) and Chloroquine Sulphate at its Solapur plant. The production of the said products will commence shortly.

EQUITYBULLS





OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2026

Technology Partner - Pairscript Software